Direct Incremental Costs in Chronic Obstructive Pulmonary Disease (COPD) and Asthma in United States - An Analysis of 2007 Medical Expenditure Panel Survey Data

Objective: To estimate national prevalence and direct incremental expenditures in Chronic Obstructive Pulmonary Disease (COPD) and asthma using 2007 Medical Expenditure Panel Survey (MEPS) data.</p><p> Methods: COPD and asthma were identified using ICD-9 codes and were the main independent variables. Covariates included age, gender, race, income, region, insurance and marital status. Dependent variables were total health care, office-based, outpatient, inpatient, emergency room and prescription expenditures. Descriptive statistics and regression analysis were used to fulfill the study objectives.</p><p> Results: Prevalence of COPD and asthma was 1.3 million and 28.3 million, respectively. Total direct incremental health care expenditures per person for COPD and asthma were $1,739.27 and $2,133.83, respectively. High cost categories among COPD and asthma included office-based, inpatient and prescription expenditures. Age, gender, region, insurance and marital status were significant predictors for health care expenditures.</p><p> Conclusion: Results highlight socio-demographic disparities and high health care expenditures due to COPD and asthma in the United States.

Name thesis:degree_name

MS

Level thesis:degree_level

Immediate Access

Discipline thesis:degree_discipline

Pharmacy Administration

Year dc:date.available

2011

Author dc:creator

• Srivastava, Bhavini

Contributors dc:contributor

• Khalid M. Kamal
• Jennifer Elliott
• Gibbs Kanyongo

• Asthma
• COPD
• Cost

Language dc:language

English

Repository record dc:identifier

https://dsc.duq.edu/etd/1232

OAI identifier oai:identifier

oai:dsc.duq.edu:etd-2248